Alice Blet
Alice Blet
MD, PhD, Hospices Civil Lyon, France
Verified email at - Homepage
Cited by
Cited by
The science underlying COVID-19: implications for the cardiovascular system
PP Liu, A Blet, D Smyth, H Li
Circulation 142 (1), 68-78, 2020
Redefining cardiac biomarkers in predicting mortality of inpatients with COVID-19
JJ Qin, XU Cheng, F Zhou, F Lei, G Akolkar, J Cai, XJ Zhang, A Blet, J Xie, ...
Hypertension 76 (4), 1104-1112, 2020
Extracorporeal life support for patients with acute respiratory distress syndrome: report of a Consensus Conference
C Richard, L Argaud, A Blet, T Boulain, L Contentin, A Dechartres, ...
Annals of intensive care 4, 1-16, 2014
Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational Adrenomedullin and Outcome in Sepsis and …
A Mebazaa, C Geven, A Hollinger, X Wittebole, BG Chousterman, A Blet, ...
Critical care 22, 1-12, 2018
Bromocriptine for the treatment of peripartum cardiomyopathy: welcome on BOARD
M Arrigo, A Blet, A Mebazaa
European heart journal 38 (35), 2680-2682, 2017
Guidelines: Anaesthesia in the context of COVID-19 pandemic
L Velly, E Gayat, H Quintard, E Weiss, A De Jong, P Cuvillon, G Audibert, ...
Anaesthesia Critical Care & Pain Medicine 39 (3), 395-415, 2020
Circulating dipeptidyl peptidase 3 is a myocardial depressant factor: dipeptidyl peptidase 3 inhibition rapidly and sustainably improves haemodynamics
B Deniau, L Rehfeld, K Santos, A Dienelt, F Azibani, M Sadoune, ...
European journal of heart failure 22 (2), 290-299, 2020
The new sepsis definition: limitations and contribution to research and diagnosis of sepsis
F Verdonk, A Blet, A Mebazaa
Current Opinion in Anesthesiology 30 (2), 200-204, 2017
Circulating dipeptidyl peptidase 3 and alteration in haemodynamics in cardiogenic shock: results from the OptimaCC trial
K Takagi, A Blet, B Levy, B Deniau, F Azibani, E Feliot, A Bergmann, ...
European journal of heart failure 22 (2), 279-286, 2020
Safety, tolerability and pharmacokinetics/pharmacodynamics of the adrenomedullin antibody adrecizumab in a first‐in‐human study and during experimental human endotoxaemia in …
C Geven, D van Lier, A Blet, R Peelen, B Ten Elzen, A Mebazaa, M Kox, ...
British Journal of Clinical Pharmacology 84 (9), 2129-2141, 2018
A double-blind, placebo-controlled, randomised, multicentre, proof-of-concept and dose-finding phase II clinical trial to investigate the safety, tolerability and efficacy of …
C Geven, A Blet, M Kox, O Hartmann, P Scigalla, J Zimmermann, G Marx, ...
BMJ open 9 (2), e024475, 2019
Prediction of an acute hypotensive episode during an ICU hospitalization with a super learner machine-learning algorithm
M Cherifa, A Blet, A Chambaz, E Gayat, M Resche-Rigon, R Pirracchio
Anesthesia & Analgesia 130 (5), 1157-1166, 2020
Low cardiac index and stroke volume on admission are associated with poor outcome in critically ill burn patients: a retrospective cohort study
S Soussi, B Deniau, A Ferry, C Levé, M Benyamina, V Maurel, ...
Annals of intensive care 6, 1-10, 2016
Management of severe thermal burns in the acute phase in adults and children
M Legrand, D Barraud, I Constant, P Devauchelle, N Donat, M Fontaine, ...
Anaesthesia Critical Care & Pain Medicine 39 (2), 253-267, 2020
Inhibition of circulating dipeptidyl-peptidase 3 restores cardiac function in a sepsis-induced model in rats: a proof of concept study
B Deniau, A Blet, K Santos, P Vaittinada Ayar, M Genest, M Kästorf, ...
PLoS One 15 (8), e0238039, 2020
Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational study
A Blet, B Deniau, K Santos, DPT van Lier, F Azibani, X Wittebole, ...
Critical care 25, 1-10, 2021
Features of inflammatory heart reactions following mRNA COVID‐19 vaccination at a global level
L Chouchana, A Blet, M Al‐Khalaf, TS Kafil, G Nair, J Robblee, MD Drici, ...
Clinical Pharmacology & Therapeutics 111 (3), 605-613, 2022
Unresponsive thrombotic thrombocytopenic purpura in critically ill adults
E Mariotte, A Blet, L Galicier, M Darmon, N Parquet, E Lengline, ...
Intensive care medicine 39, 1272-1281, 2013
ESICM LIVES 2016: part one
L Bos, L Schouten, L van Vught, M Wiewel, D Ong, O Cremer, A Artigas, ...
Intensive Care Medicine Experimental 4 (1), 27, 2016
Adrecizumab, a non-neutralizing anti-adrenomedullin antibody, improves haemodynamics and attenuates myocardial oxidative stress in septic rats
A Blet, B Deniau, C Geven, M Sadoune, A Caillard, PR Kounde, ...
Intensive Care Medicine Experimental 7, 1-13, 2019
The system can't perform the operation now. Try again later.
Articles 1–20